Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities:
Net loss	$ (3,410,899)	$ (2,672,154)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	17,547	11,147
Stock option compensation expense	57,291	116,365
Share-based compensation - common stock	4,038	$ 7,655
Common stock and warrants issued to consultants	85,200
Bad debt expense	216,505	$ 8,588
Unrealized gain on derivative instrument	(14,231)	(58,538)
Debt discount amortization	217,323	63,480
Noncash finance charges	17,591	$ 216,650
Loss on conversion of notes	63,867
Loss on settlement of note and warrant	132,301
Changes in assets and liabilities:
Receivables	(75,494)	$ 64,447
Prepaid expenses and other current assets	(187,935)	276,560
Inventory	160,000	90,000
Accounts payable, accrued expenses and other liabilities	1,641,927	312,587
Deferred revenue	13,286	(3,200)
Net cash used in operating activities	(1,061,683)	$ (1,566,413)
Cash flows from investing activities:
Purchases of property and equipment	(45,581)
Cash used in investing activities	(45,581)
Cash flows from financing activities:
Proceeds from notes payable	467,500	$ 1,549,100
Repayment of note and warrant settlement	(242,000)
Proceeds from common stock and warrants	830,500
Net cash provided by financing activities	1,056,000	$ 1,549,100
Net increase (decrease) in cash	(51,264)	(17,313)
Cash at beginning of year	57,009	74,322
Cash at end of year	$ 5,745	57,009
Supplemental Cash Flow Information
Cash Paid for interest		$ 15,304